Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Mar. 31, 2023
Assets
Cash and cash equivalents	$ 18,982	$ 454
Finance receivables held for sale, at a lower of amortized cost or fair value	38,773	0
Finance receivables held for investment, net	0	106,919
Repossessed assets held for sale, at lower of carrying value or fair value less cost to sell	668	1,491
Prepaid expenses and other assets	438	316
Income taxes receivable	902	946
Property and equipment, net	75	222
Total assets	59,838	110,348
Liabilities and shareholders’ equity
Credit facility, net of debt issuance costs	0	28,936
Accounts payable, accrued expenses, and other liabilities	996	1,603
Total liabilities	996	30,539
Commitments and contingencies (see Note 11)
Shareholders’ equity:
Preferred stock, no par: 5,000 shares authorized; none issued	0	0
Common stock, no par: 50,000 shares authorized; 12,657 shares issued and 7,289 shares outstanding as of the end of both reporting periods	35,267	35,223
Treasury stock: 5,368 common shares, at cost, as of the end of both reporting periods	(76,794)	(76,794)
Retained earnings	100,369	121,380
Total shareholders’ equity	58,842	79,809
Total liabilities and shareholders’ equity	$ 59,838	$ 110,348